Reducing the frequency of aspirating gastric tubes in patients enterally fed in the ICU: A randomised control trial
MetadataShow full item record
BACKGROUND: Enteral nutrition (EN) tolerance is monitored by aspirating stomach contents by syringe at prescribed intervals. No studies have been conducted to assess the most appropriate time interval for aspirating gastric tubes.AIM: To compare four-hourly gastric tube aspiration (usual care) to a variable regimen (up to 8-hourly aspirations).METHOD: This randomised control trial (RCT) enrolled patients who stayed in the ICU > 48 h, had a gastric tube, and were likely to receive EN for 3+ days. Patients were randomised (computer-generated randomisation) to either control group (4-hourly) or intervention group (variable regimen). The primary outcome was the number of gastric tube aspirations per number of feeding days from randomisation until EN was ceased or up to 2 weeks post-randomisation.RESULTS: Following Institutional Ethics Committee approval, 358 patients were recruited (control group n = 180 and intervention group n = 178). No differences were found in age, sex, worse Acute and Chronic Health Care Evaluation II score or time to commencement of EN. In the intention to treat analysis, the intervention group had fewer tube aspirations per feed time (0.21 versus 0.32 in the control group, p < 0.001). There were no differences in complications.CONCLUSION: This study is the first to use a RCT to examine the frequency of gastric tube aspirations. The frequency of gastric tube aspirations was reduced in the variable regimen group with no increase in risk to the patient. The reduced frequency of aspirations saves nursing time, decreases the risk of contamination of the EN circuit and minimises the risk of body fluid exposure.
Showing items related by title, author, creator and subject.
Frequency of Aspirating Gastric Tubes for Patients Receiving Enteral Nutrition in the ICU: A Randomised Controlled TrialWilliams, Teresa; Leslie, Gavin; Mills, L.; Leen, T.; Davies, Hugh; Hendron, D.; Dobb, G. (2013)Background: Enteral nutrition (EN) tolerance is often monitored by aspirating stomach contents by syringe at prescribed intervals. No studies have been conducted to assess the most appropriate time interval for aspirating ...
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trialChan, Arlene; Delaloge, S.; Holmes, F.; Moy, B.; Iwata, H.; Harvey, V.; Robert, N.; Silovski, T.; Gokmen, E.; von Minckwitz, G.; Ejlertsen, B.; Chia, S.; Mansi, J.; Barrios, C.; Gnant, M.; Buyse, M.; Gore, I.; Smith, J.; Harker, G.; Masuda, N.; Petrakova, K.; Zotano, A.; Iannotti, N.; Rodriguez, G.; Tassone, P.; Wong, A.; Bryce, R.; Ye, Y.; Yao, B.; Martin, M. (2016)Background: Neratinib, an irreversible tyrosine-kinase inhibitor of HER1, HER2, and HER4, has clinical activity in patients with HER2-positive metastatic breast cancer. We aimed to investigate the efficacy and safety of ...
Modelling the co-occurence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tractJacoby, P.; Watson, K.; Bowman, J.; Taylor, A.; Riley, T.; Smith, D.; Lehmann, Deborah (2007)Go to ScienceDirect® Home Skip Main Navigation Links Brought to you by: The University of Western Australia Library Login: + Register Athens/Institution Login Not Registered? - User Name: Password: ...